Icahn School of Medicine at Mount Sinai: Company Research Report

Company Overview

• Name: Icahn School of Medicine at Mount Sinai

• Mission: The institution is committed to advancing the art and science of medical care through an atmosphere of collaborative learning, social concern, and scholarly inquiry.

• Founded: No information is available.

• Key People:

• Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean for Academic Affairs

• Eric J. Nestler, MD, PhD, Chief Scientific Officer of Mount Sinai Health System

• Headquarters: 1 Gustave L. Levy Place, New York, NY 10029-5674

• Number of Employees: 48,000 employees across the Mount Sinai Health System

• Revenue: No information is available.

• Known For: Renowned for outstanding research, educational, and clinical care programs. It is a leading academic partner for eight hospitals in the Mount Sinai Health System.

Products

• Educational Programs:

• Offering highly competitive MD, PhD, MD-PhD, and master’s degree programs.

• Houses the largest graduate medical education program in the U.S.

• Emphasis on translational research and therapeutics.

• Research Initiatives:

• Mount Sinai Million Health Discoveries Program: Enrolls diverse patients to advance precision medicine.

• Windreich Department of AI and Human Health: Integrates AI in health systems.

• Institute for Personalized Medicine.

• Key Features:

• Integration of AI and data science.

• Collaborative research across 45 academic departments and 38 multidisciplinary institutes.

Recent Developments

• New Facilities:

• Opened the Hamilton and Amabel James Center for Artificial Intelligence and Human Health in November 2024 to transform healthcare using AI.

• New Research Initiatives:

• Study on immune-modulatory mechanisms of lurbinectedin in small-cell lung cancer.

• Research on folic acid's protective effects against liver damage from prenatal chemical exposure.

• Key Awards:

• Christine Seidman, MD, awarded the 2024 Maria I. New International Prize for Biomedical Research.

• Partnerships:

• Collaboration with IBM Research to use AI for mental health improvements.

• Lead NY coalition in NIH's All of Us Research Program, supported by $7 million funding to recruit diverse participants.

Partnerships and Collaborations

• Partnerships with industry leaders such as Merck & Co., AstraZeneca, and Novo Nordisk for research commercialization.

• Works extensively with various international research institutes to foster advancements in medical and healthcare research.